
Shelter Pharma Ltd Receives Significant International Purchase Orders from Genet International
Shelter Pharma Ltd has secured a major milestone in its growth trajectory, announcing that it has received substantial international purchase orders from Genet International. These export orders underscore the company's strengthening presence in global markets and reflect a growing success in the international business sector.The execution of these multi-product orders is expected to boost the company's revenue growth, enhance its export capabilities, and further cement its worldwide standing. The transaction falls within the normal course of business operations between both entities.
Genet International placed the order for several Veterinary Feed Supplements products, totaling USD 12,285. These supplies were ordered by an international entity, with the orders scheduled to be executed within mutually agreed timelines as per the purchase schedule.
The details of the order include various supplements and gels, which are summarized in the table below:
| Product | Quantity & Unit Rate | Value (USD) |
|---|---|---|
| FEEDMIN BOLUS | 2000x1.35 box | 2700.00 |
| REGULIN BOLUS | 2500x1.35 box | 3375.00 |
| Lactocal Gel | 1200x2.80 pcs | 3360.00 |
| BUTA-B BOLUS | 1500x1.90 box | 2850.00 |
The transaction was confirmed to be conducted at arm's length, as the company reported no interest of the promoter or promoter group in Genet International. This order is not classified as a related party transaction.
Stock Price Movement
Shelter Pharma Ltd is edging higher as of 12:11, currently trading at ₹28.98 after a strong rise of 7.73%. The shares have seen volatility during the day, bouncing between an intraday low of ₹28.50 and a high of ₹29.80.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.